Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1996 Aug;72(850):464–469. doi: 10.1136/pgmj.72.850.464

Colorectal liver metastases.

D Burke 1, T G Allen-Mersh 1
PMCID: PMC2398547  PMID: 8796208

Abstract

Each year in the UK, between 12-14,000 people develop liver metastases from colorectal cancer. These metastases will contribute to the death of the patient in about 80% of cases. Treatments aimed at these tumours are best administered when the tumour is small. Current investigative methods allow tumours as small as 0.5 mm to be detected, and should be offered to all colorectal cancer patients at risk of developing liver metastases. Surgery remains the only curative treatment for these tumours, but, unfortunately, only 20% of those who have tumour excision will survive five years. In those patients unsuitable for surgery, chemotherapy with fluoropyrimidines produces the best tumour response. This may be administered systemically or regionally, via a catheter placed within the hepatic artery. The latter approach reduces systemic toxicity, but may produce hepatotoxicity. The results of other forms of systemic chemotherapy currently undergoing clinical trials are awaited. The vast majority of patients will benefit from suitable palliative treatment delivered either locally or systemically. With the wide range of treatments now available for liver metastases, these patients are best assessed in a unit with a special interest in the problem.

Full text

PDF
464

Images in this article

465Figure 1
on p.465
465Figure 2
on p.465
466Figure 4
on p.466
466Figure 5
on p.466
467Figure 6
on p.467
467Figure 7
on p.467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen-Mersh T. G., Earlam S., Fordy C., Abrams K., Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994 Nov 5;344(8932):1255–1260. doi: 10.1016/s0140-6736(94)90750-1. [DOI] [PubMed] [Google Scholar]
  2. Allen-Mersh T. G. Improving survival after large bowel cancer. BMJ. 1991 Sep 14;303(6803):595–596. doi: 10.1136/bmj.303.6803.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allen-Mersh T. G. Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital. Ann R Coll Surg Engl. 1984 Jan;66(1):14–16. [PMC free article] [PubMed] [Google Scholar]
  4. Arbuck S. G. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer. 1989 Mar 15;63(6 Suppl):1036–1044. doi: 10.1002/1097-0142(19890315)63:6+<1036::aid-cncr2820631309>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Attiyeh F. F., Stearns M. W., Jr Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer. 1981 May 1;47(9):2119–2125. doi: 10.1002/1097-0142(19810501)47:9<2119::aid-cncr2820470903>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  6. August D. A., Ottow R. T., Sugarbaker P. H. Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev. 1984;3(4):303–324. doi: 10.1007/BF00051457. [DOI] [PubMed] [Google Scholar]
  7. Charnley R. M., Morris D. L., Dennison A. R., Amar S. S., Hardcastle J. D. Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg. 1991 Jan;78(1):45–48. doi: 10.1002/bjs.1800780116. [DOI] [PubMed] [Google Scholar]
  8. Denton G. W., Durrant L. G., Hardcastle J. D., Austin E. B., Sewell H. F., Robins R. A. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int J Cancer. 1994 Apr 1;57(1):10–14. doi: 10.1002/ijc.2910570103. [DOI] [PubMed] [Google Scholar]
  9. Durrant L. G., Buckley T. J., Denton G. W., Hardcastle J. D., Sewell H. F., Robins R. A. Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res. 1994 Sep 15;54(18):4837–4840. [PubMed] [Google Scholar]
  10. Dworkin M. J., Allen-Mersh T. G. Regional infusion chemotherapy for colorectal hepatic metastases--where is it going? Cancer Treat Rev. 1991 Dec;18(4):213–224. doi: 10.1016/0305-7372(91)90013-p. [DOI] [PubMed] [Google Scholar]
  11. Dworkin M. J., Burke D., Earlam S., Fordy C., Allen-Mersh T. G. Measurement of response to treatment in colorectal liver metastases. Br J Cancer. 1995 Apr;71(4):873–876. doi: 10.1038/bjc.1995.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Earlam S., Glover C., Fordy C., Burke D., Allen-Mersh T. G. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol. 1996 Jan;14(1):171–175. doi: 10.1200/JCO.1996.14.1.171. [DOI] [PubMed] [Google Scholar]
  13. Ekberg H., Tranberg K. G., Andersson R., Lundstedt C., Hägerstrand I., Ranstam J., Bengmark S. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986 Sep;73(9):727–731. doi: 10.1002/bjs.1800730917. [DOI] [PubMed] [Google Scholar]
  14. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res. 1986 Feb;46(2):467–473. [PubMed] [Google Scholar]
  15. Glimelius B., Hoffman K., Graf W., Påhlman L., Sjödén P. O. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Cancer. 1994 Feb 1;73(3):556–562. doi: 10.1002/1097-0142(19940201)73:3<556::aid-cncr2820730310>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  16. Greenway B. Hepatic metastases from colorectal cancer: resection or not. Br J Surg. 1988 Jun;75(6):513–519. doi: 10.1002/bjs.1800750605. [DOI] [PubMed] [Google Scholar]
  17. Hawkins M. J. Clinical trials of antiangiogenic agents. Curr Opin Oncol. 1995 Jan;7(1):90–93. [PubMed] [Google Scholar]
  18. Hemingway D. M., Cooke T. G., McCurrach G., Bessent R. G., Carter R., McKillop J. H., McArdle C. S. Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer. Br J Cancer. 1992 May;65(5):781–782. doi: 10.1038/bjc.1992.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hennigan T. W., Begent R. H., Allen-Mersh T. G. Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model. Br J Cancer. 1991 Nov;64(5):872–874. doi: 10.1038/bjc.1991.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jiang W. G., Hallett M. B., Puntis M. C. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg. 1993 Nov;80(11):1368–1373. doi: 10.1002/bjs.1800801104. [DOI] [PubMed] [Google Scholar]
  21. Kemeny M. M., Hogan J. M., Ganteaume L., Goldberg D. A., Terz J. J. Preoperative staging with computerized axial tomography and biochemical laboratory tests in patients with hepatic metastases. Ann Surg. 1986 Feb;203(2):169–172. doi: 10.1097/00000658-198602000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kemeny M. M., Sugarbaker P. H., Smith T. J., Edwards B. K., Shawker T., Vermess M., Jones A. E. A prospective analysis of laboratory tests and imaging studies to detect hepatic lesions. Ann Surg. 1982 Feb;195(2):163–167. doi: 10.1097/00000658-198202000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kemeny N., Lokich J. J., Anderson N., Ahlgren J. D. Recent advances in the treatment of advanced colorectal cancer. Cancer. 1993 Jan 1;71(1):9–18. doi: 10.1002/1097-0142(19930101)71:1<9::aid-cncr2820710104>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  24. Kemeny N. The systemic chemotherapy of hepatic metastases. Semin Oncol. 1983 Jun;10(2):148–158. [PubMed] [Google Scholar]
  25. Köhne-Wömpner C. H., Schmoll H. J., Harstrick A., Rustum Y. M. Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials. Semin Oncol. 1992 Apr;19(2 Suppl 3):105–125. [PubMed] [Google Scholar]
  26. Leen E., Goldberg J. A., Robertson J., Sutherland G. R., Hemingway D. M., Cooke T. G., McArdle C. S. Detection of hepatic metastases using duplex/color Doppler sonography. Ann Surg. 1991 Nov;214(5):599–604. doi: 10.1097/00000658-199111000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leveson S. H., Wiggins P. A., Giles G. R., Parkin A., Robinson P. J. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg. 1985 Feb;72(2):128–130. doi: 10.1002/bjs.1800720220. [DOI] [PubMed] [Google Scholar]
  28. Livraghi T., Vettori C., Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology. 1991 Jun;179(3):709–712. doi: 10.1148/radiology.179.3.2027979. [DOI] [PubMed] [Google Scholar]
  29. Lévi F. A., Zidani R., Vannetzel J. M., Perpoint B., Focan C., Faggiuolo R., Chollet P., Garufi C., Itzhaki M., Dogliotti L. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst. 1994 Nov 2;86(21):1608–1617. doi: 10.1093/jnci/86.21.1608. [DOI] [PubMed] [Google Scholar]
  30. Masters A., Steger A. C., Lees W. R., Walmsley K. M., Bown S. G. Interstitial laser hyperthermia: a new approach for treating liver metastases. Br J Cancer. 1992 Sep;66(3):518–522. doi: 10.1038/bjc.1992.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Olsen A. K. Intraoperative ultrasonography and the detection of liver metastases in patients with colorectal cancer. Br J Surg. 1990 Sep;77(9):998–999. doi: 10.1002/bjs.1800770913. [DOI] [PubMed] [Google Scholar]
  32. Onik G., Rubinsky B., Zemel R., Weaver L., Diamond D., Cobb C., Porterfield B. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer. 1991 Feb 15;67(4):901–907. doi: 10.1002/1097-0142(19910215)67:4<901::aid-cncr2820670408>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  33. Oudkerk M., van Ooijen B., Mali S. P., Tjiam S. L., Schmitz P. I., Wiggers T. Liver metastases from colorectal carcinoma: detection with continuous CT angiography. Radiology. 1992 Oct;185(1):157–161. doi: 10.1148/radiology.185.1.1523300. [DOI] [PubMed] [Google Scholar]
  34. Petrelli N., Gupta B., Piedmonte M., Herrera L. Morbidity and survival of liver resection for colorectal adenocarcinoma. Dis Colon Rectum. 1991 Oct;34(10):899–904. doi: 10.1007/BF02049705. [DOI] [PubMed] [Google Scholar]
  35. Poon M. A., O'Connell M. J., Moertel C. G., Wieand H. S., Cullinan S. A., Everson L. K., Krook J. E., Mailliard J. A., Laurie J. A., Tschetter L. K. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989 Oct;7(10):1407–1418. doi: 10.1200/JCO.1989.7.10.1407. [DOI] [PubMed] [Google Scholar]
  36. Riva P., Marangolo M., Tison V., Armaroli L., Moscatelli G., Franceschi G., Spinelli A., Vecchietti G., Morigi P., Tassini R. Treatment of metastatic colorectal cancer by means of specific monoclonal antibodies conjugated with iodine-131: a phase II study. Int J Rad Appl Instrum B. 1991;18(1):109–119. doi: 10.1016/0883-2897(91)90057-r. [DOI] [PubMed] [Google Scholar]
  37. Rougier P., Laplanche A., Huguier M., Hay J. M., Ollivier J. M., Escat J., Salmon R., Julien M., Roullet Audy J. C., Gallot D. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992 Jul;10(7):1112–1118. doi: 10.1200/JCO.1992.10.7.1112. [DOI] [PubMed] [Google Scholar]
  38. Runge V. M., Kirsch J. E., Wells J. W., Awh M. H., Bittner D. F., Woolfolk C. E. Enhanced liver MR: contrast agents and imaging strategy. Crit Rev Diagn Imaging. 1993;34(1-2):1–30. [PubMed] [Google Scholar]
  39. Scheele J. Hepatectomy for liver metastases. Br J Surg. 1993 Mar;80(3):274–276. doi: 10.1002/bjs.1800800302. [DOI] [PubMed] [Google Scholar]
  40. Semelka R. C., Shoenut J. P., Ascher S. M., Kroeker M. A., Greenberg H. M., Yaffe C. S., Micflikier A. B. Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging. 1994 May-Jun;4(3):319–323. doi: 10.1002/jmri.1880040316. [DOI] [PubMed] [Google Scholar]
  41. Shimada Y., Yoshino M., Wakui A., Nakao I., Futatsuki K., Sakata Y., Kambe M., Taguchi T., Ogawa N. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group. J Clin Oncol. 1993 May;11(5):909–913. doi: 10.1200/JCO.1993.11.5.909. [DOI] [PubMed] [Google Scholar]
  42. Soyer P., Elias D., Zeitoun G., Roche A., Levesque M. Surgical treatment of hepatic metastases: impact of intraoperative sonography. AJR Am J Roentgenol. 1993 Mar;160(3):511–514. doi: 10.2214/ajr.160.3.8430544. [DOI] [PubMed] [Google Scholar]
  43. Soyer P., Levesque M., Elias D., Zeitoun G., Roche A. Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT. AJR Am J Roentgenol. 1992 Oct;159(4):741–744. doi: 10.2214/ajr.159.4.1529835. [DOI] [PubMed] [Google Scholar]
  44. Stangl R., Altendorf-Hofmann A., Charnley R. M., Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994 Jun 4;343(8910):1405–1410. doi: 10.1016/s0140-6736(94)92529-1. [DOI] [PubMed] [Google Scholar]
  45. Tanaka T., Konno H., Matsuda I., Nakamura S., Baba S. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res. 1995 Feb 15;55(4):836–839. [PubMed] [Google Scholar]
  46. Vaillant J. C., Balladur P., Nordlinger B., Karaitianos I., Hannoun L., Huguet C., Parc R. Repeat liver resection for recurrent colorectal metastases. Br J Surg. 1993 Mar;80(3):340–344. doi: 10.1002/bjs.1800800324. [DOI] [PubMed] [Google Scholar]
  47. Vetto J. T., Hughes K. S., Rosenstein R., Sugarbaker P. H. Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma. Dis Colon Rectum. 1990 May;33(5):408–413. doi: 10.1007/BF02156268. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES